[go: up one dir, main page]

NO20021827L - Direkte kompresjons-polymer tablettkjerne - Google Patents

Direkte kompresjons-polymer tablettkjerne

Info

Publication number
NO20021827L
NO20021827L NO20021827A NO20021827A NO20021827L NO 20021827 L NO20021827 L NO 20021827L NO 20021827 A NO20021827 A NO 20021827A NO 20021827 A NO20021827 A NO 20021827A NO 20021827 L NO20021827 L NO 20021827L
Authority
NO
Norway
Prior art keywords
tablet core
aliphatic amine
amine polymer
direct compression
approx
Prior art date
Application number
NO20021827A
Other languages
English (en)
Other versions
NO20021827D0 (no
Inventor
Joseph Tyler
John S Petersen
Original Assignee
Geltex Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharma Inc filed Critical Geltex Pharma Inc
Publication of NO20021827D0 publication Critical patent/NO20021827D0/no
Publication of NO20021827L publication Critical patent/NO20021827L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives en tablettkjerne som omfatter minst ca. 95 vekt% av en alifatisk aminpolymer. Det beskrives også en fremgangsmåte for fremstilling av en tablett- kjerne som omfatter minst ca. 95 vekt% av en alifatisk aminpolymerharpiks. Frem- gangsmåten omfatter det trinn å presse den alifatiske aminpolymer slik at tablett- kjernen dannes. Tablettkjemen kan videre innbefatte ett eller flere hjelpestoffer. Denne fremgangsmåte for fremstilling av tablettkjemen omfatter trinnene: (1) hydratisering av den alifatiske aminpolymer til det ønskede fuktighetsnivå; (2) blanding av den alifatiske aminpolymer med hjelpestoffene i slike mengder at polymeren omfatter minst ca. 95 vekt% av den resulterende blanding; og (3) pressing av blandingen for å danne tablettkjemen. Det beskrives videre en drasjert tablett som omfatter en alifatisk aminpolymerkjeme, hvor drasjeringen er en vann- basert drasjering.
NO20021827A 1999-10-19 2002-04-18 Direkte kompresjons-polymer tablettkjerne NO20021827L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16025899P 1999-10-19 1999-10-19
US17422700P 2000-01-03 2000-01-03
PCT/US2000/028548 WO2001028527A2 (en) 1999-10-19 2000-10-13 Direct compression polymer tablet core

Publications (2)

Publication Number Publication Date
NO20021827D0 NO20021827D0 (no) 2002-04-18
NO20021827L true NO20021827L (no) 2002-05-29

Family

ID=26856737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021827A NO20021827L (no) 1999-10-19 2002-04-18 Direkte kompresjons-polymer tablettkjerne

Country Status (29)

Country Link
EP (1) EP1239837B1 (no)
JP (4) JP4942271B2 (no)
KR (1) KR100794427B1 (no)
CN (1) CN1202812C (no)
AR (1) AR026067A1 (no)
AT (1) ATE286386T1 (no)
AU (1) AU778262B2 (no)
BG (1) BG106626A (no)
BR (1) BRPI0015061B8 (no)
CA (1) CA2387915C (no)
CZ (1) CZ20021344A3 (no)
DE (1) DE60017285T2 (no)
EA (1) EA200200387A1 (no)
EE (1) EE200200209A (no)
ES (1) ES2235969T3 (no)
HK (1) HK1049451B (no)
HU (1) HUP0203334A2 (no)
IL (1) IL149146A0 (no)
IS (1) IS6343A (no)
MX (1) MXPA02003684A (no)
MY (1) MY125495A (no)
NO (1) NO20021827L (no)
NZ (1) NZ518334A (no)
PL (1) PL364888A1 (no)
PT (1) PT1239837E (no)
SK (1) SK5412002A3 (no)
TR (1) TR200201087T2 (no)
TW (1) TWI225413B (no)
WO (1) WO2001028527A2 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ518334A (en) * 1999-10-19 2003-08-29 Genzyme Corp Direct compression polymer tablet core
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
AU2004311849B2 (en) * 2003-12-31 2009-04-02 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
CA2806465C (en) 2004-03-30 2016-05-24 Relypsa Ion binding polymers and uses thereof
AU2012200480B2 (en) * 2004-11-01 2014-10-16 Genzyme Corporation "Aliphatic amine polymer salts for tableting"
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
BRPI0609524A2 (pt) * 2005-03-17 2011-10-18 Amgen Inc uso de uma quantidade terapeuticamente eficaz de um composto calcimimético
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
AU2006292672B2 (en) * 2005-09-15 2012-04-19 Genzyme Corporation Sachet formulation for amine polymers
RU2009111853A (ru) * 2006-09-01 2010-10-10 Юсв Лимитед (In) Способ получения гидрохлорида севеламера и его лекарственной формы
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
KR20110059750A (ko) 2008-09-02 2011-06-03 유에스브이 리미티드 가교 폴리머
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
ES2350999B1 (es) * 2009-06-26 2011-12-07 Combino Pharm, S.L. Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano).
WO2010149794A2 (en) 2009-06-26 2010-12-29 Combino Pharm, S.L. Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
WO2011047700A1 (en) * 2009-10-22 2011-04-28 Synthon B.V. Pharmaceutical compositions of sevelamer
EP2545907A1 (en) 2011-07-15 2013-01-16 Combino Pharm, S.L. Aqueous wet granulation process for cross-linked polyallylamine polymers
US9693962B2 (en) * 2012-06-05 2017-07-04 Takeda Pharmaceutical Limited Dry-coated tablet
CN102908325B (zh) * 2012-11-12 2014-07-30 南京生命能科技开发有限公司 一种碳酸司维拉姆药用片剂组合物及其制备方法
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ286958B6 (cs) * 1991-07-03 2000-08-16 Pharmacia & Upjohn Company Tabletování lékových směsí hydrochloridu colestipolu
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
JP3389493B2 (ja) * 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
NZ518334A (en) * 1999-10-19 2003-08-29 Genzyme Corp Direct compression polymer tablet core

Also Published As

Publication number Publication date
EA200200387A1 (ru) 2002-10-31
PL364888A1 (en) 2004-12-27
JP5583110B2 (ja) 2014-09-03
DE60017285T2 (de) 2005-12-08
CA2387915A1 (en) 2001-04-26
AU1088701A (en) 2001-04-30
HUP0203334A2 (hu) 2003-02-28
EP1239837A2 (en) 2002-09-18
NZ518334A (en) 2003-08-29
MXPA02003684A (es) 2002-08-30
JP2014065749A (ja) 2014-04-17
BRPI0015061B1 (pt) 2016-03-22
KR100794427B1 (ko) 2008-01-16
CZ20021344A3 (cs) 2002-08-14
CA2387915C (en) 2007-04-17
PT1239837E (pt) 2005-05-31
IL149146A0 (en) 2002-11-10
DE60017285D1 (de) 2005-02-10
CN1382041A (zh) 2002-11-27
TR200201087T2 (tr) 2002-08-21
TWI225413B (en) 2004-12-21
EP1239837B1 (en) 2005-01-05
AU778262B2 (en) 2004-11-25
SK5412002A3 (en) 2002-09-10
JP2003512317A (ja) 2003-04-02
NO20021827D0 (no) 2002-04-18
JP2012067132A (ja) 2012-04-05
BG106626A (bg) 2003-03-31
CN1202812C (zh) 2005-05-25
ES2235969T3 (es) 2005-07-16
BR0015061A (pt) 2002-07-23
WO2001028527A3 (en) 2002-01-03
JP2016000753A (ja) 2016-01-07
KR20020059629A (ko) 2002-07-13
WO2001028527A2 (en) 2001-04-26
JP4942271B2 (ja) 2012-05-30
AR026067A1 (es) 2002-12-26
IS6343A (is) 2002-04-15
JP5903111B2 (ja) 2016-04-13
HK1049451B (zh) 2005-12-16
ATE286386T1 (de) 2005-01-15
HK1049451A1 (en) 2003-05-16
BRPI0015061B8 (pt) 2021-05-25
EE200200209A (et) 2003-06-16
MY125495A (en) 2006-08-30

Similar Documents

Publication Publication Date Title
NO20021827L (no) Direkte kompresjons-polymer tablettkjerne
DK0862418T3 (da) Fremgangsmåde til fremstilling af morphologisk ensartede mikrokapsler såvel som mikrokapsler fremstillet efter denne fremgangsmåde
DE69721489D1 (de) Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen
EP0731448A3 (en) Frame erasure compensation techniques
AU2001236905A1 (en) Bioadhesive composition
DK0791037T3 (da) Fremgangsmåde til stabilisering af gelatineprodukter
AU585974B2 (en) Process for preparing polymeric particles
AU6358594A (en) Macromolecular microparticles and methods of production
ATE37982T1 (de) N-acetyl-p-aminophenol-mittel enthaltend teilweise gelierte staerke sowie verfahren zu deren herstellung.
NO964213D0 (no) Forbedret anti-flass shampo
DE50201678D1 (de) Wässrige kunststoff-dispersionen, verfahren zu deren herstellung sowie deren verwendung
EP0404184A3 (en) Process for the preparation of microvoid-containing polymer particles
ATE149826T1 (de) Verfahren zur herstellung von festen pharmazeutischen retardformen
PT1158962E (pt) Processo para a preparacao de formas de dosagem solidas que contem ciclodextrina
DK1370243T3 (da) Fremgangsmåde til at opnå mikropartikler, der indeholder en H+,K+-ATPase-inhibitor
DK0749305T3 (da) Fremgangsmåde til fremstilling af avermectin/zein-sammensætninger
MY129967A (en) New fungi for pitch reduction their production, their preparation and use
ATE288271T1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
WO2001005891A8 (de) Faserplatten aus polyaminen oder polyamin-haltigen aminoplastharzen als bindemittel
NO954858L (no) Fremgangsmåte for fremstilling av en biodegraderbar, hydrofobisk og transparent film og film oppnådd ved fremgangsmåten
AU2926800A (en) Process for the preparation of a diol
DE60328459D1 (de) Polymerisationsverfahren zur herstellung von syndiotaktischem 1,2-polybutadien
JPS5698245A (en) Curable resin composition
NO974893L (no) Preparat av tyrosin og polymerisert allergen
JPS572297A (en) Moranoline derivative and its preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application